Skip to main content
. 2020 Dec 20;47(3):566–573. doi: 10.1590/S1677-5538.IBJU.2020.0443

Table 2. Univariate and Multivariate analysis for overall survival.

Variable Univariate (95% CI) P Multivariate (95% CI) P
Type health coverage (public) 1.92 (1.25-2.94) 0.003 1.61 (1.01-2.56) 0.047
No prior nephrectomy 2.47 (1.46-4.17) 0.001 1.21 (0.64-2.29) 0.56
IMDC poor risk 3.80 (2.37-6.06) <0.001 3.15 (1.79-5.53) <0.001
ECOG ≥2 3.43 (2.15-5.45) <0.001 1.81 (1.02-3.22) 0.04
Synchronic metastasis 1.56 (1.07-2.26) 0.02 1.32 (0.86-2.03) 0.21
≥2 sites metastasis 2.02 (1.28-3.20) 0.0030 2.81 (1.67-4.71) <0.001
Non-clear cell histology 1.51 (0.94-2.44) 0.09

ECOG = Eastern Cooperative Oncology; IMDC = International Metastatic Renal Cell Carcinoma Database Consortium risk model classification; 95% CI = 95% Confidence Interval